Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,300 JPY | -1.15% | -.--% | +8.18% |
Jun. 06 | Former Takeda Employee Pleads Guilty to Defrauding Company | DJ |
Jun. 06 | Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema | MT |
Sales 2024 | 4,264B 27.22B | Sales 2025 * | 4,252B 27.14B | Capitalization | 6,640B 42.39B |
---|---|---|---|---|---|
Net income 2024 | 144B 920M | Net income 2025 * | 116B 743M | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.07B | Net Debt 2025 * | 4,224B 26.97B | EV / Sales 2025 * | 2.56 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
60
x | Employees | - |
Yield 2024 |
4.49% | Yield 2025 * |
4.58% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 month | +2.63% | ||
3 months | +4.62% | ||
6 months | -2.27% | ||
Current year | +8.18% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.44% | 754B | |
+40.95% | 630B | |
-5.82% | 352B | |
+20.00% | 331B | |
+9.57% | 298B | |
+18.45% | 250B | |
+11.88% | 217B | |
-0.78% | 216B | |
+6.20% | 164B |
- Stock Market
- Equities
- 4502 Stock
- 4502 Stock